Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine …

DR Camenga, EF Dunne, MM Desai… - Sexually transmitted …, 2013 - journals.lww.com
Background Information on genital wart incidence in adolescents and young adults before
human papillomavirus (HPV) vaccination is important for understanding the impact of the …

Trends in male and female genital warts among adolescents in a safety-net health care system 2004–2013: correlation with introduction of female and male human …

RB Perkins, A Legler, A Hanchate - Sexually Transmitted …, 2015 - journals.lww.com
Background Human papillomavirus (HPV) vaccination remains underused in the United
States, and few population-level studies on effectiveness exist. Methods We examined …

Impact of number of human papillomavirus vaccine doses on genital warts diagnoses among a national cohort of US adolescents

RB Perkins, M Lin, SF Wallington… - Sexually transmitted …, 2017 - journals.lww.com
Background The impact of fewer than 3 doses of human papillomavirus (HPV) vaccine on
genital warts is uncertain. Methods Using the Truven Health Analytics Marketscan …

Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007 …

HM Bauer, G Wright, J Chow - American journal of …, 2012 - ajph.aphapublications.org
Because of the rapid development of genital warts (GW) after infection, monitoring GW
trends may provide early evidence of population-level human papillomavirus (HPV) vaccine …

Genital warts among 18-to 59-year-olds in the United States, national health and nutrition examination survey, 1999–2004

TH Dinh, M Sternberg, EF Dunne… - Sexually transmitted …, 2008 - journals.lww.com
Background: Genital warts are caused by human papillomavirus (HPV); over 90% are due to
HPV types 6 and 11. We determined the percentage of persons who reported having been …

Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination

EW Flagg, R Schwartz… - American journal of …, 2013 - ajph.aphapublications.org
Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age
group in a large US cohort with private insurance to detect potential decreases among …

Human papillomavirus vaccine effectiveness against incident genital warts among female health-plan enrollees, United States

S Hariri, MS Schuler, AL Naleway… - American Journal of …, 2018 - academic.oup.com
We examined the effectiveness of human papillomavirus vaccination by dose number and
spacing against incident genital warts in a cohort of 64,517 female health-plan enrollees in …

Impacts of human papillomavirus immunization programs on rates of anogenital warts in British Columbia, Canada, 2000 to 2017

CD Lukac, R Donken, M Otterstatter… - Sexually Transmitted …, 2020 - journals.lww.com
Background In 2008, British Columbia (BC) implemented a school-based quadrivalent
human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015 …

Trends in the prevalence of anogenital warts among patients at sexually transmitted disease clinics—Sexually Transmitted Disease Surveillance Network, United …

LM Mann, E Llata, EW Flagg, J Hong… - The Journal of …, 2019 - academic.oup.com
Background Approximately 90% of genital warts are caused by human papillomavirus (HPV)
types 6 and 11. In the United States, HPV vaccination has been recommended for girls and …

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program …

MA Smith, B Liu, P McIntyre, R Menzies… - The Journal of …, 2015 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …